Karthik Kuppusamy is Senior Vice President, Clinical Solutions for Quest Diagnostics.
In this role, Karthik is responsible for setting and executing the strategy for growth and innovation across Quest’s clinical franchises as well as Pharma Services, Genomic Services, and Global Markets. The clinical franchises include: Cardiovascular, Metabolic and Endocrinology; Drug Monitoring & Toxicology; Infectious Disease & Immunology; Neurology; and Women’s & Reproductive Health. Working closely with Quest’s leader of Molecular Genomics and Oncology, he ensures that Quest is well positioned in advanced diagnostics with world-class tests and solutions required for physicians and patients.
Previously, Karthik served as Vice President and General Manager of Quest’s North Region, from 2018 to 2022. Prior to that, he was the General Manager of the Neurology Franchise & Consumer Genetics at Quest Diagnostics from 2014 to 2017.
He has more than 25 years of combined healthcare and life sciences experience leading large cross-functional teams. Karthik joined Quest in 2014 from GE HealthCare’s Diagnostic Imaging Division where he held General Manager roles in product development, R&D, sales, and marketing.
Karthik earned a Ph.D. in electrical and biomedical engineering from Washington University in St. Louis, an MBA in finance and operations from Marquette University, Milwaukee, a master’s degree in electrical & biomedical engineering from the Indian Institute of Technology, Madras, and a bachelor’s degree in electronics and communications engineering from Anna University, Madras, India.
Karthik is a co-chair for Quest’s Inclusion and Diversity Council.
What is Karthik Kuppusamy's net worth?
The estimated net worth of Karthik Kuppusamy is at least $1.47 million as of October 28th, 2024. Dr. Kuppusamy owns 9,734 shares of Quest Diagnostics stock worth more than $1,469,542 as of December 30th. This net worth approximation does not reflect any other assets that Dr. Kuppusamy may own. Additionally, Dr. Kuppusamy receives a salary of $840,300.00 as SVP at Quest Diagnostics. Learn More about Karthik Kuppusamy's net worth.
How old is Karthik Kuppusamy?
Dr. Kuppusamy is currently 54 years old. There are 4 older executives and no younger executives at Quest Diagnostics. The oldest executive at Quest Diagnostics is Mr. Michael E. Prevoznik, Senior VP & General Counsel, who is 62 years old. Learn More on Karthik Kuppusamy's age.
What is Karthik Kuppusamy's salary?
As the SVP of Quest Diagnostics Incorporated, Dr. Kuppusamy earns $840,300.00 per year. There are 4 executives that earn more than Dr. Kuppusamy. The highest earning executive at Quest Diagnostics is Mr. James E. Davis, Chairman, CEO & President, who commands a salary of $2,880,000.00 per year. Learn More on Karthik Kuppusamy's salary.
How do I contact Karthik Kuppusamy?
Has Karthik Kuppusamy been buying or selling shares of Quest Diagnostics?
During the past quarter, Karthik Kuppusamy has sold $278,533.00 in shares of Quest Diagnostics stock. Most recently, Karthik Kuppusamy sold 1,775 shares of the business's stock in a transaction on Monday, October 28th. The shares were sold at an average price of $156.92, for a transaction totalling $278,533.00. Following the completion of the sale, the senior vice president now directly owns 9,734 shares of the company's stock, valued at $1,527,459.28. Learn More on Karthik Kuppusamy's trading history.
Who are Quest Diagnostics' active insiders?
Quest Diagnostics' insider roster includes Mark Delaney (SVP), Michael Deppe (CAO), Catherine Doherty (SVP), Vicky Gregg (Director), Mark Guinan (CFO), Karthik Kuppusamy (SVP), Michael Prevoznik (SVP), Timothy Ring (Director), Stephen Rusckowski (CEO), Daniel Stanzione (Director), and Gail Wilensky (Director). Learn More on Quest Diagnostics' active insiders.
Are insiders buying or selling shares of Quest Diagnostics?
In the last twelve months, insiders at the medical research company sold shares 10 times. They sold a total of 39,850 shares worth more than $5,692,423.40. The most recent insider tranaction occured on November, 6th when CAO Michael J Deppe sold 18,755 shares worth more than $2,889,207.75. Insiders at Quest Diagnostics own 0.8% of the company.
Learn More about insider trades at Quest Diagnostics. Information on this page was last updated on 11/6/2024.
